Cardio-Oncology in Childhood: State of the Art

Bansal N, Blanco JG, Sharma UC, Pokharel S, Shisler S, Lipshultz SE. Cardiovascular diseases in survivors of childhood cancer. Cancer Metastasis Rev. 2020;39(1):55–68. https://doi.org/10.1007/s10555-020-09859-w.

Article  PubMed  PubMed Central  Google Scholar 

Sieswerda E, van Dalen EC, Postma A, Caron HN, Kremer LCM. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst Rev. 2009 (4). Art. No.: CD008011. https://doi.org/10.1002/14651858.CD008011.

• Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 2015;16:e123–e136. These guidelines are the result of an international effort to harmonize existing cardiomyopathy surveillance guidelines for survivors of childhood cancer.

Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991–4008.

CAS  PubMed  Article  Google Scholar 

Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein M, Lipshultz SE. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15(4):1544–52.

CAS  PubMed  Article  Google Scholar 

Cardinale D, Fabiani I, Cipolla CM. Cardiotoxicity of anthracyclines. Front Cardiovasc Med. 2020;7:26. https://doi.org/10.3389/fcvm.2020.00026.

Wojnowski L, Kulle B, Schirmer M, Schluter G, Schmidt A, Rosenberger A. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation. 2005;112:3754–62. https://doi.org/10.1161/CIRCULATIONAHA.105.576850.

Hitawala G, Jain E, Castellanos L, et al. Pediatric chemotherapy drugs associated with cardiotoxicity. Cureus. 2021;13(11): e19658. https://doi.org/10.7759/cureus.19658.

Article  PubMed  PubMed Central  Google Scholar 

• Aminkeng F, et al. Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. Br J Clin Pharmacol. 2016;82:683–95. This document provides evidence-based clinical practice recommendations for genetic testing for cancer patients prior to anthracycline chemotherapy to individualize therapy and prevent cardiotoxicity.

CAS  PubMed  PubMed Central  Article  Google Scholar 

• Garcia-Pavia P, et al. Genetic variants associated with cancer therapy-induced cardiomyopathy. Circulation. 2019; 140:31–41. This is the first study to examine the association between rare genetic variants in cardiomyopathy genes and the occurrence of cancer therapy-induced cardiomyopathy in adult and pediatric patients.

Girolami F, Spinelli V, Passantino S, Bennati E, Calabri GB, Olivotto I, Favilli S. Hidden familial cardiomyopathies in children: role of genetic testing. Int J Cardiol. 2021;340:55–8. https://doi.org/10.1016/j.ijcard.2021.08.014.

CAS  Article  PubMed  Google Scholar 

Marstrand P, et al. Second hits in dilated cardiomyopathy. Curr Cardiol Rep. 2020;22:8.

PubMed  Article  Google Scholar 

Chang VY, Wang JJ. Pharmacogenetics of chemotherapy-induced cardiotoxicity. Curr Oncol Rep. 2018;20:52.

PubMed  PubMed Central  Article  Google Scholar 

Wasielewski M, et al. Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy. Open Heart. 2014;1(1): 000116.

Article  Google Scholar 

van den Berg MP, et al. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity? Eur J Heart Fail. 2010;12:1297–9.

PubMed  Article  Google Scholar 

Young AC, Mercer B, Perren TJ, Dodwell D. Anthracycline-induced cardiomyopathy in siblings with early breast cancer. Ann Oncol. 2011;22(7):1692. https://doi.org/10.1093/annonc/mdr272.

CAS  Article  PubMed  Google Scholar 

Franco VI, Lipshultz SE. Cardiac complications in childhood cancer survivors treated with anthracyclines. Cardiol Young. 2015;25(Suppl. 2):107–16.

PubMed  Article  Google Scholar 

Lyon AR. et al. Diagnosis and treatment of left ventricular dysfunction and heart failure in cancer patients. e-Journal of Cardiology Practice 27/02/2019;16:40. https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-16/Diagnosis-and-treatment-of-left-ventricular-dysfunction-and-heart-failure-in-cancer-patients

Burke MA, Cook SA, Seidman JG, Seidman CE. Clinical and mechanistic insights into the genetics of cardiomyopathy. J Am Coll Cardiol. 2016;68:2871–86. https://doi.org/10.1016/j.jacc.2016.08.079.

Article  PubMed  PubMed Central  Google Scholar 

Simbre VC, Duffy SA, Dadlani GH, Miller TL, Lipshultz SE. Cardiotoxicity of cancer chemotherapy: implications for children. Paediatr Drugs. 2005;7(3):187–202. https://doi.org/10.2165/00148581-200507030-00005.

Article  PubMed  Google Scholar 

Mancilla TR, et al. Doxorubicin-induced cardiomyopathy in children. Compr Physiol. 2020;9(3):905–31. https://doi.org/10.1002/cphy.c180017.

Article  Google Scholar 

Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart. 2008;94(4):525–33.

CAS  PubMed  Article  Google Scholar 

Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE. Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol Hematol. 1998;27(1):53–68.

CAS  PubMed  Article  Google Scholar 

Trachtenberg BH, Landy DC, Franco VI, Henkel JM, Pearson EJ, Miller TL, Lipshultz SE. Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol. 2011;32(3):342–53.

PubMed  Article  Google Scholar 

Lipshultz SE, Scully RE, Stevenson KE, Franco VI, Neuberg DS, Colan SD, et al. Hearts too small for body size after doxorubicin for childhood leukemia: Grinch syndrome. J Clin Oncol. 2014;32:10021 (abstr.).

Article  Google Scholar 

Armenian SH, Gelehrter SK, Chow EJ. Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer. Cardiol Res Pract. 2012;2012: 713294.

PubMed  PubMed Central  Article  Google Scholar 

Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53:2231–47.

CAS  PubMed  Article  Google Scholar 

Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail. 2016;9: e002661.

PubMed  PubMed Central  Article  Google Scholar 

• Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J. 2016;2016(37):2768–801. This paper contains the latest European Guidelines on cardio-oncology.

Cardinale D, Cipolla CM. Chemotherapy-induced cardiotoxicity: importance of early detection. Expert Rev Cardiovasc Ther. 2016;14:1297–9. https://doi.org/10.1080/14779072.2016.1239528.

CAS  Article  PubMed  Google Scholar 

Cardinale D, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131:1981–8.

CAS  PubMed  Article  Google Scholar 

Pareek N, Cevallos J, Moliner P, Shah M, Tan LL, Chambers V, Baksi AJ, Khattar RS, Sharma R, Rosen SD, Lyon AR. Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience. Eur J Heart Fail. 2018;20:721–31.

Article  Google Scholar 

Lipshultz SE, et al. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol. 2012;30(10):1042–9. https://doi.org/10.1200/JCO.2010.30.3404.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Germanakis I, Kalmanti M, Parthenakis F, Nikitovic D, Stiakaki E, Patrianakos A, et al. Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol. 2006;108(2):212–5. https://doi.org/10.1016/j.ijcard.2005.05.006.

Article  PubMed  Google Scholar 

Ekstein S, Nir A, Rein AJ, Perles Z, Bar-Oz B, Salpeter L, et al. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children. J Pediatr Hematol Oncol. 2007;29(7):440–4. https://doi.org/10.1097/MPH.0b013e3180640d42.

CAS  Article  PubMed  Google Scholar 

Wolf CM, Reiner B, Kuhn A, Hager A, et al. Subclinical cardiac dysfunction in childhood cancer survivors on 10-years follow up correlates with cumulative anthracycline dose and is best detected by cardiopulmonary exercise testing, circulating serum biomarker, speckle tracking echocardiography and tissue Doppler imaging. Front Pediatr. 2020;8:123. https://doi.org/10.3389/fped.2020.00123.

Lipshultz SE, Cochran TR, Franco VI, Miller TL. Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol. 2013;10:697–710. https://doi.org/10.1038/nrclinonc.2013.195.

CAS  Article  PubMed  Google Scholar 

Bagnes C, Panchuk PN, Recondo G. Antineoplastic chemotherapy induced QTc prolongation. Curr Drug Saf. 2010;5:93–6.

CAS  PubMed  Article  Google Scholar 

Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102:14–25.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Pratila MG, Steinherz LJ, Pratilas V. Sick sinus syndrome in a teenager treated with idarubicin. J Cardiothorac Vasc Anesth. 1993;7:125–6.

CAS  PubMed  Article  Google Scholar 

Heiderneich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42:743–9.

Article  Google Scholar 

Mulrooney DA, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339: b4606. https://doi.org/10.1136/bmj.b4606.

Article  PubMed  PubMed Central  Google Scholar 

Shapiro CL. Cancer survivorship. N Engl J Med. 2018;379(25):2438–50.

PubMed  Article  Google Scholar 

Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344(26):1997–2008.

CAS  PubMed  Article  Google Scholar 

留言 (0)

沒有登入
gif